XIIlab Co. Ltd. (189330.KQ) stock: key figures, P/E, revenue and dividend
Information Technology · Application Software · South Korea
XIIlab Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.09 bn KRW | 10.27 bn KRW |
| Gross profit | 1.31 bn KRW | 2.44 bn KRW |
| Operating income | -5.28 bn KRW | -3.23 bn KRW |
| EBIT | -5.10 bn KRW | -3.07 bn KRW |
| Net income | -5.19 bn KRW | -3.12 bn KRW |
| Diluted EPS – continuing operations | -750.51 KRW | -332.46 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About XIIlab Co. Ltd.
XIIlab Co.,Ltd provides data-driven AI video analysis services in South Korea. It offers X-AIVA, an AI video analysis platform; Uyuni, an AI standard platform based on Kubenetes; X-Labeller, a video data processing solution; X-GEN, a synthetic data generation solution; and Vidigo, a cloud-based AI video and speech analysis service. The company was founded in 2010 and is headquartered in Seoul, South Korea.
More stocks
- Petros Petropoulos AEBE (PETRO.AT)
- Kukje Pharma Co Ltd (002720.KS)
- Xavi Technologies Corp. (3447.TW)
- BTCS Inc. (BTCS)
- Kentucky First Federal Bancorp (KFFB)
- JMC Electronics Co Ltd (6552.TW)
- Koryo Electronics Co Ltd (8032.TWO)
- Leenos Corp (039980.KQ)
- MiNK Therapeutics, Inc. (INKT)
- Papercorea (001020.KS)
- Kerjaya Prospek Property Bhd (7077.KL)
- OSE Pharma SA (OSE.PA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.